TACSTD2 and prostate cancer: Our recent study found that the membrane expression of Trop2 positively correlates with E-cadherin expression and negatively with the mesenchymal gene signature in a wide panel of human and murine breast and prostate cancer cell lines, as well as human tumors [137].